BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28.05.2015

Molecular Characterization of Multiple Myeloma Black/African Ancestry Disparity

The Food and Drug Administration (FDA) is announcing the availability of grant funds for the support of the efforts of the Center for Drug Evaluation and Research (CDER). FDA is announcing its intent to accept and consider a single-source application for the award of a grant to the Multiple Myeloma Service of Memorial Sloan Kettering Cancer Institute. The goal of the cooperative agreement between CDER and the Multiple Myeloma Service of Memorial Sloan Kettering Cancer Institute is to support the development of appropriate methodologies to conduct clinical trial design evaluation and determine extrapolation of findings from the general population to the U.S. Black population.

Source: Federal Register — Food and Drug AdministrationOpen original release →